HLS Therapeutics Inc.

TSX:HLS 株式レポート

時価総額:CA$111.0m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

HLS Therapeutics 配当金

配当金 基準チェック /06

HLS Therapeutics現在配当金を支払っていません。

主要情報

0%

配当利回り

0%

配当性向

業界平均利回り2.2%
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金n/a
一株当たり利益-CA$0.88
3年後の配当利回り予想6.0%

最近の配当金アップデート

HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

Apr 05
HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

HLS Therapeutics (TSE:HLS) Is Paying Out A Dividend Of $0.05

Mar 20
HLS Therapeutics (TSE:HLS) Is Paying Out A Dividend Of $0.05

HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of $0.05

Nov 30
HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of $0.05

Recent updates

Analysts Have Lowered Expectations For HLS Therapeutics Inc. (TSE:HLS) After Its Latest Results

May 12
Analysts Have Lowered Expectations For HLS Therapeutics Inc. (TSE:HLS) After Its Latest Results

After Leaping 29% HLS Therapeutics Inc. (TSE:HLS) Shares Are Not Flying Under The Radar

Apr 14
After Leaping 29% HLS Therapeutics Inc. (TSE:HLS) Shares Are Not Flying Under The Radar

Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt

Apr 06
Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt

Analysts Are More Bearish On HLS Therapeutics Inc. (TSE:HLS) Than They Used To Be

Nov 16
Analysts Are More Bearish On HLS Therapeutics Inc. (TSE:HLS) Than They Used To Be

Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt

Sep 13
Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt

Would HLS Therapeutics (TSE:HLS) Be Better Off With Less Debt?

May 05
Would HLS Therapeutics (TSE:HLS) Be Better Off With Less Debt?

HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

Apr 05
HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

HLS Therapeutics (TSE:HLS) Is Paying Out A Dividend Of $0.05

Mar 20
HLS Therapeutics (TSE:HLS) Is Paying Out A Dividend Of $0.05

HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of $0.05

Nov 30
HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of $0.05

Downgrade: Here's How Analysts See HLS Therapeutics Inc. (TSE:HLS) Performing In The Near Term

Nov 11
Downgrade: Here's How Analysts See HLS Therapeutics Inc. (TSE:HLS) Performing In The Near Term

We Think HLS Therapeutics (TSE:HLS) Has A Fair Chunk Of Debt

Sep 14
We Think HLS Therapeutics (TSE:HLS) Has A Fair Chunk Of Debt

HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

Aug 15
HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

Jul 14
HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

HLS Therapeutics (TSE:HLS) Has Announced A Dividend Of CA$0.05

Jun 23
HLS Therapeutics (TSE:HLS) Has Announced A Dividend Of CA$0.05

HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

Jun 08
HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

May 25
HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

May 10
HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

Time To Worry? Analysts Are Downgrading Their HLS Therapeutics Inc. (TSE:HLS) Outlook

Apr 30
Time To Worry? Analysts Are Downgrading Their HLS Therapeutics Inc. (TSE:HLS) Outlook

HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of CA$0.05

Apr 15
HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of CA$0.05

HLS Therapeutics (TSE:HLS) Has Re-Affirmed Its Dividend Of CA$0.05

Mar 26
HLS Therapeutics (TSE:HLS) Has Re-Affirmed Its Dividend Of CA$0.05

HLS Therapeutics Inc. (TSE:HLS) Analysts Just Slashed This Year's Estimates

Mar 22
HLS Therapeutics Inc. (TSE:HLS) Analysts Just Slashed This Year's Estimates

HLS Therapeutics (TSE:HLS) Will Pay A Dividend Of CA$0.05

Nov 29
HLS Therapeutics (TSE:HLS) Will Pay A Dividend Of CA$0.05

HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of CA$0.05

Aug 10
HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of CA$0.05

決済の安定と成長

配当データの取得

安定した配当: HLSの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。

増加する配当: HLSの配当金が増加しているかどうかを判断するにはデータが不十分です。


配当利回り対市場

HLS Therapeutics 配当利回り対市場
HLS 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (HLS)0%
市場下位25% (CA)1.9%
市場トップ25% (CA)6.7%
業界平均 (Pharmaceuticals)2.2%
3年後のアナリスト予想 (HLS)6.0%

注目すべき配当: HLSは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。

高配当: HLSは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。


株主への利益配当

収益カバレッジ: HLS Canadian市場において目立った配当金を支払っていません。


株主配当金

キャッシュフローカバレッジ: HLSが配当金を報告していないため、配当金の持続可能性を計算できません。


高配当企業の発掘